Prevalence of cervical human papillomavirus infection in women with systemic lupus erythematosus

Rheumatology International

Volumn 33, Issue 2, 2013, Pages 335-340

  Lyrio, Leomar D C ^a   Grassi, Maria Fernanda R ^b   Santana, Iuri U ^a   Olavarria, Viviana G ^a   Gomes, Aline Do N ^a   Costapinto, Licia ^a   Oliveira, Rone Peterson C ^a   Aquino, Rita De Cássia R ^a   Santiago, Mittermayer B ^a,c  

^a ESCOLA BAHIANA DE MEDICINA E SAÚDE PÚBLICA   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c SER Serviços Especializados em Reumatologia da Bahia   (Brazil)

Author keywords

Cervical cancer; Human papillomavirus; Immunosuppression; Polymerase chain reaction; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENITAL TRACT INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUALITY; SYSTEMIC LUPUS ERYTHEMATOSUS; UTERINE CERVICITIS;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; UTERINE CERVICAL DISEASES;

EID: 84873996795     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-012-2426-0     Document Type: Article

References (27)

1. Lizano M, Berumen J, Garcia-Carranca A (2009) HPV-related carcinogenesis: basic concepts, viral types and variants. Arch Med Res 40(6):428-434
2. Munoz N (2000) Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19(1-2):1-5
3. Veldhuijzen NJ, Snijders PJ, Reiss P, Meijer CJ, van de Wijgert JH (2010) Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis 10(12):862-874
4. Grinsztejn B, Veloso VG, Levi JE, Velasque L, Luz PM, Friedman RK et al (2009) Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women. Int J Infect Dis 13(1):72-80
5. Santana IU, Gomes AD, Lyrio LD, Rios Grassi MF, Santiago MB (2011) Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review. Clin Rheumatol 30(5):665-672
6. Ognenovski VM, Marder W, Somers EC, Johnston CM, Farrehi JG, Selvaggi SM et al (2004) Increased incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus treated with intravenous cyclophosphamide. J Rheumatol 31(9):1763-1767
7. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271-1277
8. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M et al (2002) The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 287(16):2114-2119
9. Richart RM (1990) A modified terminology for cervical intraepithelial neoplasia. Obstet Gynecol 75(1):131-133
10. Demathe A, Bernabé DG, Garcia JF, Nunes CM, Miyahara GI (2010) Comparação entre dois métodos de detecção de DNA de papilomavírus humano em carcinoma epidermoide de lábio. J Bras Patol Med Lab 46:85-90
11. Tam LS, Chan AY, Chan PK, Chang AR, Li EK (2004) Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection. Arthritis Rheum 50(11):3619-3625
12. Barros BRC, Matschinske R, Silva MB, Skare TL (2007) Prevalence of abnormal pap smears in patients with systemic lupus erythematosus. Rev Bras Reumatol 47(5):325-329
13. Dhar JP, Kmak D, Bhan R, Pishorodi L, Ager J, Sokol RJ (2001) Abnormal cervicovaginal cytology in women with lupus: a retrospective cohort study. Gynecol Oncol 82(1):4-6
14. Nath R, Mant C, Luxton J, Hughes G, Raju KS, Shepherd P et al (2007) High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients. Arthritis Rheum 57(4):619-625
15. Freitas TP, Carmo BB, Paula FD, Rodrigues LF, Fernandes AP, Fernandes PA (2007) Molecular detection of HPV 16 and 18 in cervical samples of patients from Belo Horizonte, Minas Gerais, Brazil. Rev Inst Med Trop Sao Paulo 49(5):297-301
16. Barber C, Gold WL, Fortin PR (2011) Infections in the lupus patient: perspectives on prevention. Curr Opin Rheumatol 23(4):358-365
17. Cuchacovich R, Gedalia A (2009) Pathophysiology and clinical spectrum of infections in systemic lupus erythematosus. Rheum Dis Clin North Am 35(1):75-93
18. Ramos-Casals M, Cuadrado MJ, Alba P, Sanna G, Brito-Zeron P, Bertolaccini L et al (2008) Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature. Medicine (Baltimore) 87(6):311-318
19. Pugliese A, Beltramo T, Torre D, Roccatello D (2007) Parvovirus B19 and immune disorders. Cell Biochem Funct 25(6):639-641
20. Aslanidis S, Pyrpasopoulou A, Kontotasios K, Doumas S, Zamboulis C (2008) Parvovirus B19 infection and systemic lupus erythematosus: activation of an aberrant pathway? Eur J Intern Med 19(5):314-318
21. Su BY, Su CY, Yu SF, Chen CJ (2007) Incidental discovery of high systemic lupus erythematosus disease activity associated with cytomegalovirus viral activity. Med Microbiol Immunol 196(3):165-170
22. Pope JE, Krizova A, Ouimet JM, Goodwin JL, Lankin M (2004) Close association of herpes zoster reactivation and systemic lupus erythematosus (SLE) diagnosis: case-control study of patients with SLE or noninflammatory nusculoskeletal disorders. J Rheumatol 31(2):274-279
23. Kawashiri S, Nakamura H, Kawakami A, Ida H, Izumi Y, Tamai M et al (2006) Emergence of Epstein-Barr virus-associated haemophagocytic syndrome upon treatment of systemic lupus erythematosus. Lupus 15(1):51-53
24. Khamaganova IV (1992) Herpetic infection in patients with lupus erythematosus. Ter Arkh 64(11):121-123
25. Nyberg G, Eriksson O, Westberg NG (1981) Increased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy. Arthritis Rheum 24(5):648-650
26. Bateman H, Yazici Y, Leff L, Peterson M, Paget SA (2000) Increased cervical dysplasia in intravenous cyclophosphamide-treated patients with SLE: a preliminary study. Lupus 9(7):542-544
27. Kay S, Frable WJ, Hume DM (1970) Cervical dysplasia and cancer developing in women on immunosuppression therapy for renal homotransplantation. Cancer 26(5):1048-1052